Current Report Filing (8-k)
April 29 2020 - 5:30PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
April
28, 2020
Date
of Report
(Date
of earliest event reported)
OZOP
SURGICAL CORP.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-55976
|
|
35-2540672
|
(State
or other jurisdiction of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
31
Sandfort Ln., Warwick NY 10990
(Address
of principal executive offices, including zip code)
(845)
544-5112
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On
April 28, 2020, Brian Conway was appointed to the Company’s Board of Directors. That same day Michael Chermak submitted
to the Board of Directors his resignation as a Director of the Company, effective that same day. A copy of Mr. Chermak’s
resignation letter is attached as exhibit 99.1 to this Current Report.
Brian
P. Conway, is the sole officer and director of the Company and brings twenty years of proven success in marketing and business
development for both private and publicly traded companies. Starting off in database management and sales for Venture Direct on
Madison Avenue, he crossed over to Wall Street first as a co-founder of Waypoint Capital Partners. During this time, he has overseen
national sales, marketing, business and product development, national account customers, and new business relations with international
and US companies while creating awareness for public companies with many of the nation’s top public relations firms. From
October 1, 2014, through August 31, 2019, Mr. Conway was the CEO, CFO and Director of Ngen Technologies, Inc. (f/k/a/ Liberated
Solutions, Inc.). His relationships and experience with investment bankers, non-dilutive financing, and public relations should
be instrumental in moving the Company forward in the upcoming months.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated:
April 29, 2020
|
OZOP
SURGICAL CORP.
|
|
|
|
By:
|
/s/
Brian Conway
|
|
Name:
|
Brian
Conway
|
|
Title:
|
Chief
Executive Officer
|
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Apr 2023 to Apr 2024